Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesFesoterodine: a new antimuscarinic for overactive bladder
Aging Health, 10/13/09
Guay DRP – Fesoterodine therapy (4 and 8 mg once daily) significantly reduced the numbers of micturitions and urge incontinence episodes per 24 h and increased the volume voided per micturition as compared with placebo in three published randomized, controlled trials. It has been compared with tolterodine long–acting in one of these randomized, controlled trials, but the results of fesoterodine and tolterodine long–acting were not compared statistically. Fesoterodine produces the same well–known adverse events as other urinary anticholinergics. The initial recommended dosage regimen is 4 mg once daily, which can be titrated up to 8 mg once daily based upon response. However, the following patient populations should not receive over 4 mg daily: patients with severe renal impairment (creatinine clearance <30 ml/min) and those receiving concurrent therapy with potent CYP450 isozyme 3A4 inhibitors (e.g., ketoconazole, itraconazole, voriconazole, clarithromycin, ritonavir and nelfinavir).
Related Articles
Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity
BJU International, 11/11/09
Relevance Score: 88%
Fesoterodine for the treatment of urinary incontinence and overactive bladder
Therapeutics and Clinical Risk Management, 11/05/09
Relevance Score: 88%
Objective differences between overactive bladder patients with and without urodynamically proven detrusor overactivity
International Urogynecology Journal, 11/17/09
Relevance Score: 80%
Bladder problems could be linked to mental health
Internet Source, 10/28/09
Relevance Score: 80%
Is ultrasound estimation of bladder weight a useful tool in the assessment of patients with lower urinary tract symptoms
International Urogynecology Journal, 10/07/09
Relevance Score: 80%
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders
Journal of Dermatological Treatment , 12/04/09
Non-psoriatic dermatologic uses of monoclonal antibody therapy
Journal of Dermatological Treatment , 12/04/09
Does Simvastatin Cause More Myotoxicity Compared with Other Statins
Annals of Pharmacotherapy, 12/03/09
Sponsor
Article Search
Sponsor